Mirion Technologies (MIR) Stock Price & Analysis
MIR Stock Chart & Stats
- Day’s Range
- MXN 280.17 - MXN 280.17
- 52-Week Range
- MXN 280.17 - MXN 562.40
- Previous Close
- MXN 280.17
- Volume
- 3,720
- Average Volume (3M)
- 2,604
- Market Cap
- MXN 84.75B
- Enterprise Value
- MXN 4.73B
- Total Cash (Recent Filing)
- MXN 419.00M
- Total Debt (Recent Filing)
- MXN 1.24B
- Price to Earnings (P/E)
- 158.2
- Beta
- 0.07
- Next Earnings
- Feb 16, 2027 (Est.)
- EPS Estimate
- 3.98
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Backlog Visibility
The sharp backlog increase provides meaningful revenue visibility beyond the current quarter and supports planning for the next several periods. Higher future-year backlog and 95% revenue coverage reduce reliance on near-term order timing, while supporting sustained growth and operating leverage.
Installed-Base Position
Broad penetration across the global reactor fleet creates a durable installed-base advantage and recurring exposure to monitoring, upgrades, services, and compliance needs. Because most nuclear revenue comes from operating reactors, the business is positioned to benefit from fleet investment and life extensions.
Cash Generation
Improving operating cash flow and free cash flow strengthen Mirion's ability to fund investment, reduce debt, and support capital returns without relying solely on external financing. The rise in cash conversion also indicates that reported growth is increasingly translating into financial flexibility.
Bears Say
Margin Pressure
Withdrawal of the near-term 30% margin target shows that profitability improvement may take longer than previously expected. Medical growth moderation, slower Paragon margin expansion, and front-loaded AI and cybersecurity spending can limit operating leverage and constrain earnings growth over the next several periods.
Leverage
The higher debt load reduces balance-sheet flexibility and leaves less room for acquisitions, buybacks, or unexpected operating weakness. Although management expects leverage to improve, current leverage and low returns on equity increase sensitivity to execution, refinancing conditions, and cash-flow variability.
Uneven Medical Demand
Uneven medical-market conditions create a durable headwind for one of Mirion's major end markets and can delay the contribution from otherwise attractive products. Slower regional demand and below-expectation medical margin expansion may limit consolidated growth and reduce the pace of profit improvement.
MIR FAQ
What was Mirion Technologies’s price range in the past 12 months?
What is Mirion Technologies’s market cap?
When is Mirion Technologies’s upcoming earnings report date?
How were Mirion Technologies’s earnings last quarter?
Is Mirion Technologies overvalued?
Does Mirion Technologies pay dividends?
What is Mirion Technologies’s EPS estimate?
How many shares outstanding does Mirion Technologies have?
What happened to Mirion Technologies’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Mirion Technologies?
What is the TipRanks Smart Score and how is it calculated?
Mirion Technologies Stock Smart Score
Company Description
Mirion Technologies
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
- Sector
- Industrials
- Industry
- Industrial - Machinery
- CEO
- Thomas D. Logan
- Employees
- 3,281
- Website
- www.mirion.com
- Address
- 1218 Menlo Drive, Atlanta, GA, 30318, US
Mirion Technologies (MIR) Earnings & Revenues
MIR Company Deck
MIR Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Highlights included substantial order growth, expanding backlog, higher revenue and EBITDA, raised revenue and free cash flow guidance, strong nuclear and SMR momentum, and improved cash generation. The main challenges were margin pressure, withdrawal of the near-term 30% margin target, uneven medical-market conditions, AI-related front-loaded spending, and the need to reduce leverage below 3.0x by year end. Management remained constructive about fourth-quarter acceleration and the outlook for 2027.
View all MX:MIR earnings summariesMIR Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 1 | 14 |
| Technical Analysis | 3 | 1 | 3 |
| Moving Averages | 1 | 0 | 11 |
